New Mexico Alumni in MLB | Week of Sept. 11–17, 2026
The most significant news out of the New Mexico alumni community this week came on a difficult note: Red Sox reliever Justin Slaten has been ruled out for the remainder of the 2026 season, a gut-punch for a Boston club still clinging to playoff aspirations.
Interim manager Chad Tracy confirmed the news, describing Slaten's diagnosis as "degenerative changes in his flexor mass." The right-hander received a platelet-rich plasma injection in an attempt to manage the condition, but the Red Sox made clear there is no realistic path back to the mound before the regular season ends. It's a significant loss — Sports Illustrated noted Slaten as one of Boston's best relievers, underscoring just how much the bullpen will feel his absence down the stretch.
The timing couldn't be worse. Boston is navigating a high-stakes final stretch of the season, and losing a reliable late-inning arm forces Tracy to reshuffle pieces in a bullpen that was already operating under postseason-level pressure every night. Slaten, a product of New Mexico's pitching pipeline, had carved out a legitimate role in a major-league bullpen — the kind of success story Lobo fans follow closely. Watching that story get interrupted by a degenerative arm issue, rather than a clean ending to the season, stings.
The Lobos do have another name on Boston's roster worth watching: outfielder Phillip Sikes continues to hold a spot on the Red Sox as a center fielder. With the team fighting for October, every roster decision becomes amplified — including whether Sikes factors into the club's crunch-time outfield mix.
Elsewhere around the league, New Mexico alumni are scattered across the diamond. Mitch Garver is behind the plate for the Mariners, Sam Haggerty is patrolling left field for the Rangers, and Isaac Gallegos is in the Braves' bullpen. Dylan Jasso is holding down first base for the Marlins, while the Orioles' Luis Gonzalez is working out of the rotation as a pitcher — distinct from the Yankees' outfielder of the same name, who remains in New York's lineup.
But the story of the week, undeniably, belongs to Slaten. Degenerative injuries don't carry the dramatic finality of a torn UCL, but they carry their own uncertainty — the kind that raises questions about timelines that extend well beyond this September. For Red Sox fans and Lobo alumni alike, the hope is that an offseason of treatment and rest gives Slaten a clear runway back to the mound in 2027.
For now, Boston will have to navigate the playoff push without one of its most trusted arms.
AI-generated summary
